HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target
Arcadia Biosciences, Inc. -3.42%
Arcadia Biosciences, Inc. RKDA | 1.35 | -3.42% |
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:
RKDA) with a Buy and maintains $10 price target.
